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Abstract 
Background: Rab3A is a GTP-binding protein and plays critical roles in the regulation of synaptic vesicle exocytosis. 
Up to date, how Rab3A participates in such a regulatory process is not completely clear.
Results: In this report the Rab3A gene from Rattus norvegicus was cloned and heterologously expressed in E. coli 
using pCold-TF expression vector with folding capacity. Due to the presence of His-tag sequence on the N-terminal 
side, Rab3A fusion protein was purified to greater than 95 % purity with a single Ni-affinity purification step. After the 
Rab3A fusion protein was used to immunize mice, an anti-serum against Rab3A with a titer of about 6000 was gener-
ated. Western blot analysis indicated that the prepared polyclonal antibody could recognize both Rab3A fusion pro-
tein and native Rab3A protein. To remove the tag sequence, thrombin was used to cleave the Rab3A fusion protein, 
followed by SDS-PAGE to separate the cleavage products. Using the gel protein recovery strategy with a Micro Protein 
PAGE Recovery Kit, the de-tagged Rab3A protein of electrophoretic purity was prepared.
Conclusions: The present work not only prepared the ground for the study on Rab3A-mediated protein interactions, 
but also provided systematic experimental methods referable for the similar studies.
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Background
Rab proteins belong to the Ras superfamily of small 
GTPases and play central roles in the regulation of vesi-
cle formation, actin- and tubulin-dependent movement 
and fusion (Stenmark and Olkkonen 2001). The major 
Rab protein in brain is Rab3A, which is able to associate 
with synaptic vesicle membranes by a C-terminal lipid 
modification (Geppert et al. 1994; Johnston et al. 1991). 
This protein associates with synaptic vesicles in its GTP-
bound form and dissociates from the vesicles upon GTP 
hydrolysis or depolarization of the nerve terminal (Fis-
cher von Mollard et  al. 1994). Rab3A cycles between a 
soluble GDP-bound and a membrane-associated GTP-
bound states, suggesting that there may be a mechanism 
that removes the protein from the membranes and thus 
neatly exerts its regulatory function (Geppert and Süd-
hof 1998). Indeed, evidences show that the protein GDP 
dissociation inhibitor (GDI) inhibits GDP dissociation 
from Rab3A by binding to GDP-bound Rab proteins and 
removes them from membranes (Araki et al. 1990; Gar-
rett et al. 1993). The GDP/GTP exchange protein (GEP) 
catalyzes the conversion of GDP-bound state to GTP-
bound state, bringing Rab3A back to membranes (Wada 
et  al. 1997), whereas GTPase activating protein (GAP) 
catalyzes the reverse conversion (Fukui et al. 1997). The 
three types of regulators, GDI, GEP and GAP, coordi-
nately control the Rab3A cycling, whereas Rab3A inter-
acts with multiple factors through the same effector 
domain (McKiernan et al. 1993).
How Rab3A participates in the regulation of synaptic 
vesicle exocytosis is not completely clear. It most likely 
acts via its effector proteins. Up to now several proteins 
have been found to be the effectors of Rab3A. Rabphilin-
3A, as an upstream Rab3A effector, has an N-terminal 
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Rab3A binding domain and strongly inhibits the Rab3A 
GTPase-activating protein (GAP)-stimulated GTPase 
activity of Rab3A (Kishida et  al. 1993). RIM is referred 
to as a downstream Rab3A effector because it associates 
with Rab3A only at the active zone, regulating synaptic-
vesicle fusion (Wang et  al. 1997). Afterwards, Giovedì 
et  al. (2004) confirmed that synapsin is a novel Rab3A 
effector protein on small synaptic vesicles. The presence 
of synapsin I stimulates GTP binding and GTPase activ-
ity of both purified and endogenous synaptic vesicle-
associated Rab3A. In view of the crucial regulatory roles 
of Rab3A in exocytosis of synaptic vesicles, a great deal 
of genetic, overexpression, electrophysiological, and bio-
chemical studies sought to address on the mechanism of 
action of Rab3A. However, the results are divergent and 
some are contradictory (Stenmark and Olkkonen 2001; 
Geppert and Südhof 1998; Bustos et al. 2014). Thus much 
work needs to be done in the relevant field.
There have been evidences suggesting that the critical 
regulation of the synaptic vesicle exocytosis is mediated 
by two proteins with opposite actions: synaptotagmin, a 
Ca2+-binding protein that is essential for Ca2+-triggered 
release and probably serves as the Ca2+-sensor in fusion, 
and Rab3, which limits the number of vesicles that can be 
fused as a function of Ca2+ in order to allow a temporally 
limited, repeatable signal. Thus, Rab3 and synaptotagmin 
are considered as the Yin and Yang of synaptic membrane 
fusion (Geppert and Südhof 1998). However, the related 
mechanism has not been completely understood. In the 
present research, we present the gene cloning, expres-
sion and polyclonal antibody preparation of Rab3A. The 
functionalities of the prepared products were evaluated 
in the interaction between Rab3A and synaptotagmin I, 
and results suggested that these products can be used as 




E. coli Top10 and E. coli BL21 (DE3) were purchased 
from Novagen, Inc. (San Diego, CA, USA) and stored in 
our lab. The expression vector pCold-TF was from Takara 
Bio (Dalian, China). Restriction enzymes NdeI and SalI 
were from Thermo Fisher (MA, USA). Ni–NTA Agarose 
was from Thermo Fisher (Invitrogen, USA). Thrombin 
CleanCleave™ Kit was purchased from Sigma Aldrich (St 
Louis, MO, USA). Micro Protein PAGE Recovery Kit was 
from Sangon Biotech. Co. Ltd. (Shanghai, China). Other 
chemicals were of analytical or higher grade available.
Cloning of Rab3A gene from Rattus norvegicus
Rattus norvegicus hippocampal tissues were used as 
Rab3A gene source. The total RNA was extracted from 
the hippocampal tissues and the first-strand DNA syn-
thesis was performed according to the instructions of 
cDNA reverse transcription kit (Thermo Fisher Sci-
entific, Waltham, MA, USA). The DNA was used as 
the template to obtain Rab3A gene by PCR amplifica-
tion with the forward primer containing NdeI recogni-
tion site (5ʹ-GGGAATTCCATATGGCCTCAGCCAC
AGACTCTC-3ʹ) and the reverse primer containing SalI 
recognition site (5ʹ-ACGCGTCGACTCAGCAGGC 
GCAATCCTGAT-3ʹ). PCR was completed under the fol-
lowing conditions: preincubation for 3 min at 98 °C, fol-
lowed by 32 cycles of 20 s at 98 °C, 20 s at 60 °C, 40 s at 
68 °C, and then a final extension step of 72 °C for 30 min. 
The PCR products were subjected to electrophoresis 
on a 1.2 % agarose gel. The recovered and purified PCR 
fragment with a size of about 660  bp was ligated into 
pMD18T vector and then transformed into E. coli Top10, 
which were incubated in 1 ml LB fluid medium at 37 °C 
for 45 min with shaking (220 rpm) and then plated onto 
LB agar plates containing ampicillin (100 µg/ml). The sin-
gle positive colonies were picked out and the plasmids 
were extracted. After digestion with NdeI and SalI, the 
positive colonies were confirmed by DNA sequencing. 
Recombinant plasmid (pMD18T-Rab3A) was digested 
with restriction endonucleases NdeI and SalI and the 
resulting Rab3A gene fragments were ligated into the 
expression vector pCold-TF which had been digested 
with the same enzymes. Then the ligated plasmid pCold-
TF-Rab3A was transformed into E. coli BL21(DE3).
Expression and purification of Rab3A fusion protein
The recombinant plasmids encoding Rab3A were trans-
formed into E. coli BL21 (DE3) by heat shock and the cells 
were plated onto LB agar plates with 100 µg/ml ampicil-
lin, followed by incubation overnight at 37 °C. Single colo-
nies from plates were transferred to 5 ml LB fluid medium 
containing 100 µg/ml ampicillin and incubated overnight 
at 37 °C with shaking at 220 rpm. This culture was diluted 
1:100 into 500  ml LB broth plus ampicillin (100  µg/ml). 
The cells were grown at 37  °C until an OD600 of 0.6–1.0 
was reached. After the temperature was reduced to 16 °C, 
the recombinant expression was induced by the addition 
of IPTG at a final concentration of 0.5 mM and the cells 
were grown overnight in an incubator with constant shak-
ing of 220 rpm. The cells were harvested by centrifugation 
at 4000 g for 20 min at 4 °C. Cell pellet was re-suspended 
in a lysis buffer at a ratio of 5 ml buffer per 1 g cell pel-
let, followed by sonication. After centrifugation at 4000g 
at 4 °C, the supernatant was transferred into 15 ml Falcon 
tubes containing 200  µl of Ni–NTA Agarose and incu-
bated on a rotating wheel for 3  h at 4  °C. The Ni–NTA 
Agarose with bound protein was separated from the lysate 
by centrifugation at 500g at 4 °C and washed three times. 
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In the final step, the bound proteins were eluted from the 
Ni–NTA Agarose with 400 µl of 50 mM Hepes (pH 8.0) 
buffer containing 500 mM NaCl and 250 mM imidazole 
(elution buffer). An aliquot of the eluted proteins were 
analyzed by SDS-PAGE.
SDS‑PAGE and western blot analysis
Samples of Rab3A heterologous expression and purifica-
tion were resolved on a 10 % SDS-PAGE gel in principle 
as described by Laemmli (1970), followed by visualiza-
tion with Coomassie brilliant blue staining and scanning 
with a G:BOX Gel imaging system (Syngene, Cambridge, 
UK). For further identification of the expressed Rab3A 
fusion protein, the protein in the corresponding band was 
transferred from gel lane onto a nitrocellulose membrane 
(PALL Corporation, USA) using a blot electrotransfer 
apparatus in the wet transfer method (100 mA/2.5 h) and 
blocked in 5  % milk/TBST (50  mM Tris–HCl, 150  mM 
NaCl, 0.1 % Tween-20, pH 7.5) for 1.5 h at room tempera-
ture, and then probed with the mouse anti-His tag anti-
body (Novex, Life Technology, USA) (1:5000 dilution in 
5 % milk/TBST) for 1.5 h at room temperature. After the 
membrane was washed three times (each for 6 min) using 
TBST, it was incubated with goat anti-mouse IgG conju-
gated with horseradish peroxidase (Promega Corporation, 
Madison, WI, USA) (1:8000 dilution in 5 % milk/TBST), 
followed by washing with TBST extensively. The blot was 
developed using the enhanced chemiluminescence (ECL) 
method (Thermo Scientific, USA) and recorded with a 
ChemiDoc XRS imaging system (Bio-Rad, USA).
Antibody generation of Rab3A fusion protein and western 
blot analysis
The commonly used immunization protocols were 
employed to generate polyclonal antibody to Rab3A pro-
tein (Cooper and Paterson 2001). Briefly, the recombinant 
Rab3A (about 800  µg/ml in PBS) was mixed with equal 
volume of Freund’s incomplete adjuvant and injected 
subcutaneously into two 4- to 6-month-old mice. Initial 
immunization was followed by three booster injections at 
2-week intervals. Antiserum was collected from the ani-
mals after 14 weeks. Antibody verification using western 
blotting was performed similarly to the identification of 
the expressed Rab3A fusion protein described as above, 
with the newly generated polyclonal antibody as the first 
antibody instead of anti-His tag antibody (1:4000 dilution 
in 5 % milk/TBST). Both recombinant and native Rab3A 
proteins were used as antigens.
Tag sequence removal and de‑tagged Rab3A protein 
purification
In order to remove the tag sequence from Rab3A fusion 
protein, the purified fusion protein was cleaved with 
thrombin. For optimizing the experimental conditions, 
the enzymolysis was performed and compared at dif-
ferent thrombin concentrations and for different times. 
After enzymolysis, the resulting protein mixture were 
electrophoresed on a 12  % SDS-PAGE, followed by gel 
protein recovery using a Micro Protein PAGE Recovery 
Kit according to the manufacturer’s instructions.
GST pull‑down and western blotting
GST pull-down experiment was used to detect a repre-
sentative Rab3A-mediated protein interaction. For this 
detection, GST-Syt I-C2AB (the cytoplasmic C2 domains 
of synaptotagmin I) preparation and GST pull-down assay 
were performed according to the procedures previously 
described (Chapman and Jahn 1994). Glutathione-Sepha-
rose bead-bound Syt I-C2AB was incubated with recom-
binant Rab3A protein overnight at 4  °C in a HNa buffer 
(10  mM Hepes–NaOH, 150  mM NaCl, 1  µM pepstatin 
A, 2  µM leupeptin, 0.3  mM phenylmethylsulfonyl fluo-
ride, pH 7.4) containing 0.5 % Triton X-100. After incuba-
tion, the Glutathione-Sepharose beads were washed three 
times each with 1 ml of the HNa buffer containing 0.1 % 
TritonX-100. The proteins that remained bound to the 
beads were eluted with 2× SDS loading buffer and were 
analyzed by 10  % SDS-PAGE, followed by immunoblot-
ting with the anti-Rab3A polyclonal antibody we prepared 
and anti-GST antibody (Abcam, England) as the primary 
antibodies, and horseradish peroxidase (HRP)-conjugated 
anti-mouse lgG antibody as the second antibody.
Results
Cloning of Rab3A gene
The cDNA for the hippocampal RNA was prepared 
using reverse transcription and used as the template to 
obtain Rab3A gene by PCR amplification using Rab3A-
specific primers. Figure  1a shows the agarose gel elec-
tropherogram of PCR amplification products in which 
a bright band of about 660 bp was the band of interest. 
The resulting fragments encoding Rab3A were subcloned 
into pMD18T vector. The recombinant plasmid was iden-
tified by restriction enzyme digestion and sequencing. 
The double enzyme digestion of the recombinant plas-
mids demonstrated that the fragments were successfully 
ligated into the vectors (Fig.  1b). Sequencing confirmed 
that the sequence of cloned fragment was correct (data 
not shown). Then the gene was successfully cloned into 
the expression vector pCold-TF and transformed into E. 
coli BL21(DE3) for heterologous expression.
Heterologous expression and affinity purification of Rab3A 
fusion protein
For optimizing the experimental conditions for heter-
ologous expression, after the expression vector pCold-TF 
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was transformed into E. coli BL21(DE3), the expression 
was induced with 0.5 mM IPTG (final concentration) at 
different combinations of temperature and time (37  °C 
for 4  h, 28  °C for 7  h and 16  °C overnight). The results 
showed that the expression efficiencies of Rab3A fusion 
protein were similar at above different combinations 
(data not shown). 16  °C-overnight (16  h) combina-
tion was chosen as the experimental conditions. The 
expressed fusion protein was purified using nickel-affin-
ity Agarose beads, eluted with imidazole. The purity 
of the protein samples from each step was analyzed by 
SDS-PAGE (Fig. 2). As it is shown in Fig. 2, the content 
of Rab3A fusion protein in the sample after IPTG induc-
tion (lane 2) was much higher than that before induction 
(lane 1), suggesting the high expression efficiency. After 
a single-step affinity purification based on the His tag of 
Rab3A fusion protein, the purity of the protein sample 
was estimated to be greater than 95 % (lane 3). For fur-
ther confirmation of the Rab3A fusion protein, we made 
a western blot analysis of the protein using anti-His tag 
antibody as the primary antibody. The result indicated 
that there was a band appearing in western blot at the 
position corresponding to that of the Rab3A fusion pro-
tein on the gel lane, suggesting that His-tagged Rab3A 
fusion protein was successfully expressed (lane 4).
Preparation and characterization of the antibody 
against Rab3A protein
Using the purified Rab3A fusion protein as antigen to 
immunize mice, the antiserum against Rab3A protein 
was successfully prepared. Indirect ELISA assay demon-
strated that the titer of the antiserum was about 1:6000 
(Fig. 3). In order to detect the specificity of the prepared 
polyclonal antibody, we used the mouse serum as the pri-
mary antibody to detect the Rab3A fusion protein as well 
as the native Rab3A in the extract from rat hippocampal 
tissues in a western blot experiment. The results (Fig. 4) 
showed that the antibody recognizes both Rab3A fusion 
protein and native Rab3A protein, demonstrating that the 
newly prepared polyclonal antibody can be used in the 
research on the Rab3A-mediated protein interactions.
Tag sequence removal and de‑tagged Rab3A protein 
purification
The Rab3A fusion protein expressed with expression vec-
tor pCold TF has a fairly large tag sequence consisting of 
trigger factor (TF) and His6-tag, etc. For obtaining desired 
de-tagged Rab3A protein, thrombin was used to cleave the 
Fig. 1 Agarose gel electropherograms of the products of Rab3A PCR 
amplification (a) and the recombinant vector digestion by NdeI and 
SalI (b). Lanes labelled with 1 in (a) and (b) represent the products 
of PCR amplification and double digestion, respectively. M, DNA 
molecular weight marker
Fig. 2 Induction expression, affinity purification and confirmation of 
Rab3A fusion protein. Lane 1, total proteins (35 μg) before induction; 
lane 2, total proteins (35 μg) after induction with IPTG; lane 3, the puri-
fied Rab3A fusion protein; lane 4, western blotting of Rab3A fusion 
protein. M, protein molecular weight marker
Fig. 3 Titer determination of antiserum against Rab3A fusion protein. 
1, negative control; 2–7, 1:1000, 1:2000,1:3000, 1:4000, 1:5000 and 
1:6000, respectively
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fusion protein according to the instructions of the enzyme 
supplier, followed by SDS-PAGE and gel protein recov-
ery using a Micro Protein PAGE Recovery Kit to prepare 
the desired de-tagged Rab3A protein. SDS-PAGE analy-
sis (Fig.  5) showed that, under the present experimental 
conditions, thrombin cleavage resulted in three main pro-
tein bands. Based on their molecular weights, it could be 
speculated that they were uncleaved fusion protein, tag 
sequence and de-tagged Rab3A protein, respectively (lane 
3 in Fig. 5). After the gel slice containing de-tagged Rab3A 
was excised, destained and mashed, the de-tagged Rab3A 
protein with high purity was obtained from the gel by 
repeated extraction (lanes 4 and 5 in Fig. 5).
Detection of Rab3A interaction with synaptotagmin I
In view of the fact that the C2 domains of the synaptotag-
min I are its functional domains (Geppert and Südhof 
1998; Chapman 2008), we used the C2 domains GST 
fusion protein (GST-Syt I-C2AB) to further evaluate the 
prepared polyclonal antibody and the functionality of 
recombinant Rab3A. After GST pull-down using GST-
Syt I-C2AB as the bait protein and recombinant Rab3A 
as the prey protein, western blot analysis with the pre-
pared polyclonal antibody as the first antibody showed 
that Rab3A could interact with the C2 domains (Fig. 6), 
demonstrating the functionality of purified Rab3A.
Discussion
Due to the multiple important physiological roles of 
Rab3A protein in the cells, much attention has been 
attracted to the structure and functions of the protein. 
However, the low abundance of the protein in tissues that 
leads to the impossibility to obtain satisfactory amounts 
of the protein from the natural sources limits its deep 
research. Obviously, heterologous expression is a useful 
alternative to the native extraction (Paukner et al. 2015; 
Papaneophytou and Kontopidis 2014; Zhang et al. 2014) 
and provides a simple and inexpensive means to produce 
large amounts recombinant Rab3A protein.
Generally speaking, owing to the continuous develop-
ment and improvement of PCR technique, the cloning 
of a gene with known nucleotide sequence is relatively 
easy. Comparatively, protein expression and purification 
are more difficult because they involve many issues, such 
as the selection of optimal expression organism, high 
efficiency expression vector, most appropriate growth 
condition, efficient purification strategy, etc., which in 
turn depend on the protein characteristics and down-
stream requirements (Ferrer-Miralles et  al. 2015). The 
production of soluble and functional recombinant pro-
teins is among the goals in the heterologous expression 
field. In the present work, we used a fusion expression 
vector (pCold TF) newly developed by Takara Bio Inc. 
(Shiga, Japan). pCold TF is a fusion cold shock expres-
sion vector that expresses trigger factor chaperone as a 
Fig. 4 Western blot detection of Rab3A fusion protein (a) and native 
Rab3A protein (b) with prepared polyclonal antibody. Lanes 1 and 2 in 
(a) were Rab3A fusion protein with different loading amounts
Fig. 5 SDS-PAGE of Rab3A fusion protein before and after cleavage 
with thrombin. Lanes 1 and 2, Rab3A fusion protein with different 
loading amounts before cleavage (10 μg per lane). Lane 3, protein 
mixture after cleavage with thrombin (10 μg per lane). Lanes 4 and 5, 
purified de-tagged Rab3A protein with different loading amounts
Fig. 6 Detection of Rab3A interaction with the C2 domains of 
synaptotagmin I
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soluble fusion tag. This vector provides cold shock tech-
nology for high yield protein expression, combined with 
TF to facilitate correct protein folding (Saini et al. 2014; 
Qing et al. 2004). Our experimental results showed that 
Rab3A fusion protein was indeed efficiently expressed 
using pCold TF vector (Fig.  2). Furthermore, Rab3A 
fusion protein was efficiently purified in a single Ni-
affinity purification step. Nevertheless, when we used 
thrombin to cleave the fusion protein, we found that the 
enzyme could not completely cleave the fusion protein 
even at higher concentrations. However, the data that 
Takara provided indicated that thrombin could almost 
completely remove the tag sequence of enzyme protein 
C fusion protein (Bio View Takara Bio Europe Edition), 
suggesting that the experimental conditions for the tag 
sequence removal of TF fusion proteins are depend-
ent on the properties of the fusion proteins. Besides, 
Factor Xa was also tentatively used to cleave the fusion 
protein. However, the effect was found to be worse than 
that using thrombin (data not shown). Furthermore, 
when we tried to use Ni-affinity purification to separate 
the cleaved tag sequence as well as uncleaved fusion 
protein from the de-tagged Rab3A, we found that the 
purification efficiency was very limited, as it was hardly 
to obtain pure de-tagged Rab3A from the protein mix-
ture, although we had made much effort on the optimi-
zation of experimental conditions (data not shown). It 
was speculated that the changes in the conformation of 
the tag sequences impeded their His tag binding to the 
agarose beads. In addition, gel filtration and RP-HPLC 
(using C4 column) were also tentatively employed to 
purify the de-tagged Rab3A protein, and, however, they 
all failed. Finally, the gel protein recovery strategy using 
a Micro Protein PAGE Recovery Kit was employed to 
recover the de-tagged Rab3A protein after SDS-PAGE. 
Using this method, the pure Rab3A protein can be easily 
obtained, although it is usually difficult to prepare large 
amounts of the sample. Fortunately, due to the develop-
ment of the techniques in protein chemistry, many anal-
yses based on micro amounts of sample have become 
possible. It is worth mentioning that it is better not to 
use reducing reagents such as DTT to treat protein sam-
ple before SDS-PAGE and not to fix the gel after SDS-
PAGE, which is in favor of renaturation and extraction 
of the protein of interest. Furthermore, preparative gel 
electrophoresis can be used to enlarge the scale of sam-
ple preparation, and Native-PAGE would be helpful to 
produce Rab3A of higher quality.
Protein–protein interactions represent the key events 
in various cellular processes and the study on such inter-
actions is of growing interest. Antibodies are often used 
to detect the interacting proteins in many protein interac-
tion researches such as co-immunoprecipitation (Co-IP), 
pull-down and western blotting, etc. Although there are 
a wide variety of antibodies commercially available, some 
special antibodies and those needed in a relatively large 
amounts are usually made by oneself. Of the several kinds 
of methods for antibody preparation, polyclonal antibody 
preparation is often the first choice in a laboratory due to 
its easiness to operate, low cost and needing no complex 
devices (Cooper and Paterson, 2001; Novo et  al. 2010). 
In our present work, in view of the high-level expression 
of the Rab3A fusion protein, we used the fusion protein 
rather than de-tagged Rab3A protein as antigen to raise 
polyclonal antibody. The titer determination and western 
blot detection indicated that the polyclonal antibody was 
successfully produced. More importantly, the antibody 
could specifically recognize both recombinant Rab3A in 
the fusion protein and native Rab3A protein, which sug-
gested that the newly prepared polyclonal antibody can 
be used in the researches on the Rab3A-mediated pro-
tein–protein interactions.
Conclusions
Rab3A gene from R. norvegicus was successfully cloned 
and highly efficiently expressed as a fusion protein in E. coli 
using cold shock expression vector pCold TF with folding 
capacity. The polyclonal antibody raised against the fusion 
protein could specifically recognize both Rab3A fusion 
protein and native Rab3A protein. Comparatively, throm-
bin is more efficient than Factor Xa in the cleavage of the 
tag sequence of the fusion. The de-tagged Rab3A protein 
can be completely purified from the cleavage product mix-
ture using a combined strategy of SDS-PAGE separation 
and gel protein recovery. This work not only prepared a 
basis for the further research on Rab3A-mediated protein 
interactions, but also provides systematic experimental 
methods referable for the similar studies.
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